review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Derek Middleton | |
Faviel Gonzelez | |||
P2860 | cites work | Plasticity in the organization and sequences of human KIR/ILT gene families | Q24676718 |
IPD--the Immuno Polymorphism Database | Q24793789 | ||
Genomic organization of the human leukocyte immunoglobulin-like receptors within the leukocyte receptor complex on chromosome 19q13.4 | Q28143512 | ||
Recognition of HLA-G by the NK cell receptor KIR2DL4 is not essential for human reproduction | Q28180558 | ||
Multiple copies of KIR 3DL/S1 and KIR 2DL4 genes identified in a number of individuals | Q28182135 | ||
Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism | Q28201347 | ||
Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype | Q28203016 | ||
KIR: diverse, rapidly evolving receptors of innate and adaptive immunity | Q28203441 | ||
New allele frequency database: http://www.allelefrequencies.net | Q28204761 | ||
Crucial role of DNA methylation in determination of clonally distributed killer cell Ig-like receptor expression patterns in NK cells | Q28205984 | ||
Distinctive KIR and HLA diversity in a panel of north Indian Hindus | Q28208283 | ||
Cutting edge: induction of IFN-gamma production but not cytotoxicity by the killer cell Ig-like receptor KIR2DL4 (CD158d) in resting NK cells | Q28211347 | ||
In search of the 'missing self': MHC molecules and NK cell recognition | Q28250846 | ||
Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors | Q28259065 | ||
Human diversity in killer cell inhibitory receptor genes | Q28259075 | ||
Investigation of killer cell immunoglobulin-like receptor gene diversity V. KIR3DL2 | Q28276414 | ||
Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues | Q28755874 | ||
Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3. | Q29568902 | ||
Three common alleles of KIR2DL4 (CD158d) encode constitutively expressed, inducible and secreted receptors in NK cells | Q40195850 | ||
KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand | Q40364675 | ||
Investigation of killer cell immunoglobulin-like receptor gene diversity III. KIR2DL3. | Q40537600 | ||
Investigation of killer cell immunoglobulin-like receptor gene diversity: IV. KIR3DL1/S1. | Q40541366 | ||
The protein made from a common allele of KIR3DL1 (3DL1*004) is poorly expressed at cell surfaces due to substitution at positions 86 in Ig domain 0 and 182 in Ig domain 1. | Q40609313 | ||
The silent KIR3DP1 gene (CD158c) is transcribed and might encode a secreted receptor in a minority of humans, in whom the KIR3DP1, KIR2DL4 and KIR3DL1/KIR3DS1 genes are duplicated. | Q43746260 | ||
Receptor systems controlling natural killer cell function are genetically stratified in Europe | Q44761632 | ||
Unusual selection on the KIR3DL1/S1 natural killer cell receptor in africans | Q46103159 | ||
KIR2DL5 alleles mark certain combination of activating KIR genes | Q46129965 | ||
Global diversity and evidence for coevolution of KIR and HLA. | Q46442901 | ||
SNP haplotypes and allele frequencies show evidence for disruptive and balancing selection in the human leukocyte receptor complex | Q46950949 | ||
Cutting edge: expansion of the KIR locus by unequal crossing over | Q47677728 | ||
Distinct diversity of KIR genes in three southern Indian populations: comparison with world populations revealed a link between KIR gene content and pre-historic human migrations | Q47700353 | ||
Some human KIR haplotypes contain two KIR2DL5 genes: KIR2DL5A and KIR2DL5B. | Q52842649 | ||
Low expression of inhibitory natural killer receptors in CD8 cytotoxic T lymphocytes in long-term non-progressor HIV-1-infected patients | Q58377913 | ||
High KIR diversity in Amerindians is maintained using few gene-content haplotypes | Q59624570 | ||
Human NK-cell receptors | Q61719167 | ||
Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002 | Q73443956 | ||
The genomic organization and evolution of the natural killer immunoglobulin-like receptor (KIR) gene cluster | Q73769951 | ||
Genomic diversity of natural killer cell receptor genes in three populations | Q73943144 | ||
Genotyping of human killer-cell immunoglobulin-like receptor genes by polymerase chain reaction with sequence-specific primers: an update | Q74326676 | ||
A single polymorphism disrupts the killer Ig-like receptor 2DL2/2DL3 D1 domain | Q79174425 | ||
KIR haplotype content at the allele level in 77 Northern Irish families | Q79479235 | ||
Killer immunoglobulin receptor gene and allele frequencies in Caucasoid, Oriental and Black populations from different continents | Q80172310 | ||
The reactivity of Bw4+ HLA-B and HLA-A alleles with KIR3DL1: implications for patient and donor suitability for haploidentical stem cell transplantations | Q81007095 | ||
Facilitation of KIR genotyping by a PCR-SSP method that amplifies short DNA fragments | Q81248308 | ||
Duplication, mutation and recombination of the human orphan gene KIR2DS3 contribute to the diversity of KIR haplotypes | Q81279319 | ||
Structural and functional differences between the promoters of independently expressed killer cell Ig-like receptors | Q81821260 | ||
Organization of the leukocyte receptor cluster (LRC) on human chromosome 19q13.4. | Q31919135 | ||
Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia | Q33378868 | ||
Chimpanzees use more varied receptors and ligands than humans for inhibitory killer cell Ig-like receptor recognition of the MHC-C1 and MHC-C2 epitopes | Q33789518 | ||
Rapid evolution of NK cell receptor systems demonstrated by comparison of chimpanzees and humans | Q33909456 | ||
Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. | Q34056087 | ||
Natural killer cell immunoglobulin-like receptor (KIR) locus profiles in African and South Asian populations | Q34124327 | ||
A common KIR2DS4 deletion variant in the human that predicts a soluble KIR molecule analogous to the KIR1D molecule observed in the rhesus monkey | Q34160230 | ||
Divergent and convergent evolution of NK-cell receptors | Q34207553 | ||
Investigation of killer cell immunoglobulin-like receptor gene diversity: II. KIR2DS4. | Q34329262 | ||
The genomic context of natural killer receptor extended gene families | Q34341455 | ||
KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations | Q34627802 | ||
A bioinformatics approach to ascertaining the rarity of HLA alleles. | Q35005761 | ||
Immunogenetics of killer-cell immunoglobulin-like receptors | Q35212392 | ||
Shaping the human NK cell repertoire: an epigenetic glance at KIR gene regulation | Q35988380 | ||
MHC class I molecules and KIRs in human history, health and survival | Q36047157 | ||
Complex interactions: the immunogenetics of human leukocyte antigen and killer cell immunoglobulin-like receptors | Q36104562 | ||
KIR genes | Q36176599 | ||
Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function | Q36228467 | ||
The impact of variation at the KIR gene cluster on human disease. | Q36331620 | ||
NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. | Q36363753 | ||
Dramatically reduced surface expression of NK cell receptor KIR2DS3 is attributed to multiple residues throughout the molecule | Q36366692 | ||
Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success | Q36399286 | ||
The Yin and Yang of HLA and KIR in human disease | Q36410540 | ||
KIR and disease: a model system or system of models? | Q36652201 | ||
Human natural killer cells | Q36787596 | ||
Killer cell immunoglobulin-like receptors on NK cells: the how, where and why. | Q37037744 | ||
Role of KIRs and KIR ligands in hematopoietic transplantation | Q37233484 | ||
The LRC haplotype project: a resource for killer immunoglobulin-like receptor-linked association studies | Q37324146 | ||
Natural killer cells: integrating diversity with function | Q37412618 | ||
Studies on the expression of the deleted KIR2DS4*003 gene product and distribution of KIR2DS4 deleted and nondeleted versions in different populations | Q39250115 | ||
Investigation of killer cell immunoglobulinlike receptor gene diversity: I. KIR2DL4. | Q39595268 | ||
Investigation of killer cell immunoglobulin-like receptor gene diversity, KIR2DL1 and KIR2DS1. | Q39958919 | ||
Killer cell immunoglobulin-like receptor allele discrimination by high-resolution melting. | Q39964264 | ||
Investigation of killer cell immunoglobulin-like receptor (KIR) gene diversity: KIR2DL2, KIR2DL5 and KIR2DS5. | Q39979469 | ||
P433 | issue | 1 | |
P304 | page(s) | 8-19 | |
P577 | publication date | 2010-01-01 | |
P1433 | published in | Immunology | Q15754984 |
P1476 | title | The extensive polymorphism of KIR genes | |
P478 | volume | 129 |
Q37790771 | A Practical Approach to the Flow Cytometric Detection and Diagnosis of T-Cell Lymphoproliferative Disorders |
Q38568874 | A bird's eye view of NK cell receptor interactions with their MHC class I ligands |
Q36764620 | A database for curating the associations between killer cell immunoglobulin-like receptors and diseases in worldwide populations |
Q56557489 | A gene-specific primer extension and liquid bead array system for killer cell immunoglobulin-like receptor genotyping |
Q39596685 | A gene-specific primer extension and liquid bead array system for killer-cell immunoglobulin-like receptor genotyping |
Q37094767 | A method for killer-cell immunoglobulin-like receptor (KIR) 3DL1/3DS1 genotyping using DNA recovered from frozen plasma |
Q40598773 | A multifaceted computational report on the variants effect on KIR2DL3 and IFNL3 candidate gene in HCV clearance |
Q36048703 | Activating KIR/HLA complexes in classic Kaposi's Sarcoma |
Q39208685 | Activating Killer Immunoglobulin Receptors and HLA-C: a successful combination providing HIV-1 control |
Q36122304 | An analytical workflow for accurate variant discovery in highly divergent regions |
Q38930242 | An overview of the potential strategies for NK cell-based immunotherapy for acute myeloid leukemia |
Q89896458 | Analysis of Killer Immunoglobulin-Like Receptor Genes in Colorectal Cancer |
Q92072055 | Association of Functional Polymorphisms of KIR3DL1/DS1 With Behçet's Disease |
Q86514424 | Association of killer cell immunoglobulin-like receptor and human leucocyte antigen-Cw gene combinations with systemic lupus erythematosus |
Q61806794 | Association study between KIR polymorphisms and rheumatoid arthritis disease: an updated meta-analysis |
Q36773601 | Characterisation of an epigenetically altered CD4(+) CD28(+) Kir(+) T cell subset in autoimmune rheumatic diseases by multiparameter flow cytometry |
Q35833809 | Complete haplotype phasing of the MHC and KIR loci with targeted HaploSeq |
Q90664677 | Conserved and variable natural killer cell receptors: diverse approaches to viral infections |
Q36775731 | Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donors |
Q33796633 | Distribution of HLA-A, -B, and -C alleles and HLA/KIR combinations in Han population in China. |
Q42266309 | Distribution of KIR genes in Han population in Yunnan Province: comparison with other Han populations in China. |
Q92129058 | Distribution of Killer-Cell Immunoglobulin-Like Receptor Genes and Combinations of Their Human Leucocyte Antigen Ligands in 11 Ethnic Populations in China |
Q46598731 | Distribution of killer cell immunoglobulin-like receptor genes in Roma from Republic of Macedonia |
Q43667282 | Distribution of killer cell immunoglobulin-like receptor genes in population of Vojvodina, Serbia |
Q103805662 | Diversity of KIRs in invasive breast cancer patients and healthy controls along with the clinical significance in ER/PR/HER2+ patients |
Q35187793 | Diversity of killer cell immunoglobulin-like receptor (KIR) genotypes and KIR2DL2/3 variants in HCV treatment outcome |
Q39752148 | Diversity of killer cell immunoglobulin-like receptor genes in four ethnic groups in China. |
Q33701536 | Does the KIR2DS5 gene protect from some human diseases? |
Q27010680 | Epistasis and immunity: the role of genetic interactions in autoimmune diseases |
Q90745727 | Estimation of German KIR Allele Group Haplotype Frequencies |
Q34756153 | Evaluating genome architecture of a complex region via generalized bipartite matching |
Q35664654 | Evaluation of host genetics on outcome of tuberculosis infection due to differences in killer immunoglobulin-like receptor gene frequencies and haplotypes |
Q46093357 | Evolutionary genetics of immunological supertypes reveals two faces of the Red Queen |
Q34577195 | Expansions of NK-like αβT cells with chronologic aging: novel lymphocyte effectors that compensate for functional deficits of conventional NK cells and T cells |
Q33818321 | Gender and population history: sex bias revealed by studying genetic admixture of Ngazidja population (Comoro Archipelago). |
Q39157513 | Genetics of Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): current knowledge and future directions |
Q37709330 | Genomic clues to ethnic differences in ALL. |
Q55154779 | Genotype B of Killer Cell Immunoglobulin-Like Receptor is Related with Gastric Cancer Lesions. |
Q33847355 | HLA DNA sequence variation among human populations: molecular signatures of demographic and selective events |
Q39219822 | HLA class I, KIR, and genome-wide SNP diversity in the RV144 Thai phase 3 HIV vaccine clinical trial |
Q37051248 | HLA/KIR restraint of HIV: surviving the fittest |
Q55172823 | High-Risk Leukemia: Past, Present, and Future Role of NK Cells. |
Q40109884 | High-resolution phenotyping identifies NK cell subsets that distinguish healthy children from adults |
Q59355249 | Human CD49a Lung Natural Killer Cell Cytotoxicity in Response to Influenza A Virus |
Q40097257 | Human Leukocyte Antigen (HLA) and Immune Regulation: How Do Classical and Non-Classical HLA Alleles Modulate Immune Response to Human Immunodeficiency Virus and Hepatitis C Virus Infections? |
Q38238690 | Human gene copy number variation and infectious disease |
Q37083519 | Human migration, diversity and disease association: a convergent role of established and emerging DNA markers |
Q48253044 | Identification of an elaborate NK-specific system regulating HLA-C expression. |
Q34536026 | Immune mechanisms and the impact of the disrupted lung microbiome in chronic bacterial lung infection and bronchiectasis. |
Q42283039 | Immune regulation in idiopathic bronchiectasis |
Q28740417 | Immunogenetics as a tool in anthropological studies |
Q38258161 | Immunology of hematopoietic stem cell transplant. |
Q35693475 | Impact of "Killer Immunoglobulin-Like Receptor /Ligand" Genotypes on Outcome following Surgery among Patients with Colorectal Cancer: Activating KIRs Are Associated with Long-Term Disease Free Survival |
Q36255385 | Impact of Donor Activating KIR Genes on HSCT Outcome in C1-Ligand Negative Myeloid Disease Patients Transplanted with Unrelated Donors-A Retrospective Study |
Q92783338 | Impact of Tumor and Immunological Heterogeneity on the Anti-Cancer Immune Response |
Q38772230 | Impact of killer-immunoglobulin-like receptor and human leukocyte antigen genotypes on the efficacy of immunotherapy in acute myeloid leukemia |
Q47990258 | Improved full-length killer cell immunoglobulin-like receptor transcript discovery in Mauritian cynomolgus macaques |
Q34070433 | Innate Immune Natural Killer Cells and Their Role in HIV and SIV Infection |
Q51500135 | Interactions between killer immunoglobulin-like receptors and their human leucocyte antigen Class I ligands influence the outcome of unrelated haematopoietic stem cell transplantation for thalassaemia: a novel predictive algorithm. |
Q47563920 | Is There Natural Killer Cell Memory and Can It Be Harnessed by Vaccination? Natural Killer Cells in Vaccination |
Q34398420 | KIR B haplotype donors confer a reduced risk for relapse after haploidentical transplantation in children with ALL. |
Q42247194 | KIR and HLA interactions are associated with control of primary CMV infection in solid organ transplant recipients |
Q54273648 | KIR gene variability in cutaneous malignant melanoma: influence of KIR2D/HLA-C pairings on disease susceptibility and prognosis. |
Q38411219 | KIR genotype distribution among Lebanese patients with Hodgkin's lymphoma |
Q36154501 | KIR repertory in patients with hematopoietic diseases and healthy family members |
Q39317288 | KIR, LILRB and their Ligands' Genes as Potential Biomarkers in Recurrent Implantation Failure |
Q50888961 | KIR-HLA-A and B alleles of the Bw4 epitope against HIV infection in discordant heterosexual couples in Chaco Argentina. |
Q36532802 | KIR2DL3 and KIR2DL1 show similar impact on licensing of human NK cells |
Q35171437 | KIR2DS5 in the presence of HLA-C C2 protects against endometriosis |
Q35610533 | Killer Cell Immunoglobulin-like Receptors and Their HLA Ligands are Related with the Immunopathology of Chagas Disease. |
Q90408365 | Killer cell immunoglobulin-like receptors (KIR) and human leukocyte antigen-C (HLA-C) allorecognition patterns in women with endometriosis |
Q54215205 | Killer immunoglobulin like receptor gene content diversity among Northern Indian population. |
Q34427302 | Killer immunoglobulin-like receptor (KIR) and HLA genotypes affect the outcome of allogeneic kidney transplantation. |
Q34826271 | Killer immunoglobulin-like receptor (KIR) centromeric-AA haplotype is associated with ethnicity and tuberculosis disease in a Canadian First Nations cohort. |
Q33705522 | Linkage disequilibrium organization of the human KIR superlocus: implications for KIR data analyses |
Q33638985 | Multigene families of immunoglobulin domain-containing innate immune receptors in zebrafish: deciphering the differences |
Q90384454 | NK Cells in the Treatment of Hematological Malignancies |
Q37689434 | NK Cells: Uncertain Allies against Malaria |
Q35539280 | NK cells and immune "memory" |
Q60947027 | Natural Killer Cell Education Is Associated With a Distinct Glycolytic Profile |
Q44526861 | No impact of KIR-ligand mismatch on allograft outcome in HLA-compatible kidney transplantation |
Q37402472 | Ocular toxoplasmosis: susceptibility in respect to the genes encoding the KIR receptors and their HLA class I ligands |
Q45187685 | Partial duplication of chromosome 19 associated with syndromic duane retraction syndrome |
Q38656322 | Patients Lacking a KIR-Ligand of HLA Group C1 or C2 Have a Better Outcome after Umbilical Cord Blood Transplantation |
Q27681812 | Polymorphisms in the Human Inhibitory Signal-regulatory Protein Do Not Affect Binding to Its Ligand CD47 |
Q43896693 | Polymorphisms of killer immunoglobulin-like receptors (KIRs) and HLA ligands in northeastern Thais |
Q61650838 | Possible KIR-driven genetic pressure on the genesis and maintenance of specific HLA-A,B haplotypes as functional genetic blocks |
Q88085342 | Prognostic role of KIR genes and HLA-C after hematopoietic stem cell transplantation in a patient cohort with acute myeloid leukemia from a consanguineous community |
Q37227774 | Racial differences in the incidence and clearance of human papilloma virus (HPV): the HPV in men (HIM) study |
Q35077002 | Receptor-ligand requirements for increased NK cell polyfunctional potential in slow progressors infected with HIV-1 coexpressing KIR3DL1*h/*y and HLA-B*57 |
Q57471119 | Report from the Killer-cell Immunoglobulin-like Receptors (KIR) component of the 17 International HLA and Immunogenetics Workshop |
Q37171499 | Role of KIR and CD16A genotypes in colorectal carcinoma genetic risk and clinical stage. |
Q36471507 | Skin Cancer Risk Is Modified by KIR/HLA Interactions That Influence the Activation of Natural Killer Immune Cells |
Q37012868 | Structure and function of major histocompatibility complex class I antigens |
Q38200088 | TLR/NCR/KIR: Which One to Use and When? |
Q92538362 | The Dual Role of HLA-C in Tolerance and Immunity at the Maternal-Fetal Interface |
Q98735801 | The Enigma of Low COVID-19 Fatality Rate in India |
Q36691438 | The favorable role of homozygosity for killer immunoglobulin-like receptor (KIR) A haplotype in patients with advanced-stage classic Hodgkin lymphoma |
Q39433520 | The ly49 gene family. A brief guide to the nomenclature, genetics, and role in intracellular infection |
Q33413512 | The presence of KIR2DS5 confers protection against adult immune thrombocytopenia |
Q60046855 | Tuning Natural Killer Cell Anti-multiple Myeloma Reactivity by Targeting Inhibitory Signaling KIR and NKG2A |
Q34754902 | Under representation of the inhibitory KIR3DL1 molecule and the KIR3DL1+/BW4+ complex in HIV exposed seronegative individuals. |
Q96431447 | Variations in killer-cell immunoglobulin-like receptor and human leukocyte antigen genes and immunity to malaria |
Q28075219 | What Unrelated Hematopoietic Stem Cell Transplantation in Thalassemia Taught us about Transplant Immunogenetics |
Search more.